These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 3102055
1. Synergy between low-dose chemotherapy and immunotherapy in mouse L1210 leukemia. Relyveld EH, Bizzini B, Ophir R, Ben-Efraim S. Cancer Treat Rep; 1987 Mar; 71(3):241-6. PubMed ID: 3102055 [Abstract] [Full Text] [Related]
4. [Prevention and therapy of L1210 leukemia in mice, using inactivated and grafted tumor cells, in association with the immunomodulator P40, and Antineoplastic Agents (author's transl)]. Relyveld EH, Bizzini B, Ben-Efraim S. C R Seances Acad Sci III; 1982 Mar 22; 294(12):571-6. PubMed ID: 6809234 [Abstract] [Full Text] [Related]
6. Immunotherapeutic response of concanavalin A-bound L1210 vaccine enhanced by a streptococcal immunopotentiator, OK-432. Kataoka T, Oh-hashi F, Sakurai Y. Cancer Res; 1979 Jul 22; 39(7 Pt 1):2807-10. PubMed ID: 445486 [Abstract] [Full Text] [Related]
7. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity. Ujiie T. Jpn J Cancer Res; 1987 Jul 22; 78(7):737-47. PubMed ID: 3114200 [Abstract] [Full Text] [Related]
8. Immunoprophylactic and immunotherapeutic response by concanavalin A-bound tumor vaccine enhanced by chemotherapeutic agents eliminating possible suppressors. Kataoka T, Ogihara K, Sakurai Y. Cancer Res; 1980 Oct 22; 40(10):3839-45. PubMed ID: 6449286 [Abstract] [Full Text] [Related]
10. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine. Kataoka T, Akahori Y, Sakurai Y. Cancer Res; 1984 Feb 22; 44(2):519-24. PubMed ID: 6537896 [Abstract] [Full Text] [Related]
11. Production of antitumor T-cells in tumor-bearing mice treated with tumor vaccine and 6-mercaptopurine. Kataoka T, Oh-hashi F. Cancer Res; 1985 Jul 22; 45(7):2962-6. PubMed ID: 3873988 [Abstract] [Full Text] [Related]
16. Chemotherapy-increased antineoplastic effects of antibody-toxin conjugates. Sironi M, Canegrati MA, Romano M, Vecchi A, Spreafico F. Cancer Treat Rep; 1984 Apr 22; 68(4):643-5. PubMed ID: 6713420 [Abstract] [Full Text] [Related]
17. Chemotherapy and immunotherapy of L1210 leukemic mice with antigenic tumor sublines. Nicolin A, Canti G, Marelli O, Veronese F, Goldin A. Cancer Res; 1981 Apr 22; 41(4):1358-62. PubMed ID: 7011535 [Abstract] [Full Text] [Related]
18. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy. Griswold DP, Trader MW, Frei E, Peters WP, Wolpert MK, Laster WR. Cancer Res; 1987 May 01; 47(9):2323-7. PubMed ID: 3567926 [Abstract] [Full Text] [Related]
19. L1210 leukemia regression in non-immunosuppressed mice with therapeutic transfer of immune spleen cells--therapeutic adoptive transfer against L1210 leukemia. Kawashima K, Nagura E, Nagase F, Kumazawa T, Nakashima I, Yamada K. Nihon Ketsueki Gakkai Zasshi; 1987 Sep 01; 50(6):1174-82. PubMed ID: 3687342 [No Abstract] [Full Text] [Related]
20. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors. Nitta K, Tanaka T, Takeuchi M. Cancer Treat Rep; 1985 Mar 01; 69(3):285-91. PubMed ID: 3978657 [Abstract] [Full Text] [Related] Page: [Next] [New Search]